logo

Eiger Biopharmaceuticals Inc. (EIGR)



Trade EIGR now with
  Date
  Headline
1/16/2018 12:20:45 PM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $34 Price Target
1/16/2018 8:48:32 AM Eiger Shares Plummet 40% After Phase 2 Lung Trial Failure
1/8/2018 8:15:57 AM Eiger BioPharmaceuticals Appoints Eldon Mayer To Its Board
1/3/2018 8:08:02 AM Eiger BioPharma Says Appoints David Apelian As COO
12/19/2017 6:30:37 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) 2018 Estimate To -3.42 From -5.14
12/19/2017 6:30:22 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q4 18 Estimate To -0.84 From -1.28
12/19/2017 6:30:07 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q3 18 Estimate To -0.85 From -1.28
12/19/2017 6:29:53 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q2 18 Estimate To -0.86 From -1.28
12/19/2017 6:29:39 AM Wedbush Is Raising Eiger BioPharmaceuticals Inc. (EIGR) Q1 18 Estimate To -0.87 From -1.29
12/19/2017 6:29:13 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) 2017 Estimate To -3.88 From -5.22
12/19/2017 6:29:01 AM Wedbush Is Increasing Eiger BioPharmaceuticals Inc. (EIGR) Q4 17 Estimate To -0.88 From -1.25
11/9/2017 8:12:41 AM Eiger BioPharmaceuticals Q3 Net Loss $9.2 Mln Or $1.10/Shr
10/27/2017 9:18:36 AM Eiger BioPharmaceuticals Prices Public Offering Of 1.85 Mln Shares At $10/Shr
10/25/2017 9:55:09 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Outperform With $34 Price Target
9/5/2017 8:14:03 AM Eiger: FDA Orphan Drug Designation Granted For Pegylated Interferon Lambda In Hepatitis Delta Virus Infection
8/14/2017 9:50:48 AM Wedbush Reiterates Eiger BioPharmaceuticals Inc. (EIGR) At Ourperform With $34 Price Target